Detalhe da pesquisa
1.
Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson's Disease through a Commercial Smartwatch.
Sensors (Basel)
; 23(21)2023 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37960670
2.
Aloe-Emodin Overcomes Anti-Cancer Drug Resistance to Temozolomide and Prevents Colony Formation and Migration in Primary Human Glioblastoma Cell Lines NULU and ZAR.
Molecules
; 28(16)2023 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37630276
3.
Step-Counting Accuracy of a Commercial Smartwatch in Mild-to-Moderate PD Patients and Effect of Spatiotemporal Gait Parameters, Laterality of Symptoms, Pharmacological State, and Clinical Variables.
Sensors (Basel)
; 23(1)2022 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36616812
4.
The tolerability, safety and efficacy of safinamide in elderly Parkinson's disease patients: a retrospective study.
Aging Clin Exp Res
; 33(6): 1689-1692, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32681474
5.
Up-regulation of the Trace Amine Receptor, TAAR-1, in the Prefrontal Cortex of Individuals Affected by Schizophrenia.
Schizophr Bull
; 50(2): 374-381, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897399
6.
Metabotropic Glutamate Receptors Type 3 and 5 Feature the "NeuroTransmitter-type" of Glioblastoma: A Bioinformatic Approach.
Curr Neuropharmacol
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509672
7.
The Story behind the Mask: A Narrative Review on Hypomimia in Parkinson's Disease.
Brain Sci
; 14(1)2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38275529
8.
Monoamine-oxidase Type B Inhibitors and Cognitive Functions in Parkinson's Disease: Beyond the Primary Mechanism of Action.
Curr Neuropharmacol
; 21(5): 1214-1223, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36065929
9.
Age at Onset Influences Progression of Motor and Non-Motor Symptoms during the Early Stage of Parkinson's Disease: A Monocentric Retrospective Study.
Brain Sci
; 13(2)2023 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831700
10.
Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism.
Neuropharmacology
; 238: 109642, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392820
11.
Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint.
Curr Neuropharmacol
; 20(1): 107-125, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-33784961
12.
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease.
Front Neurol
; 13: 909197, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35785358
13.
Switch from rasagiline to safinamide in fluctuating Parkinson's disease patients: a retrospective, pilot study.
Neurol Res
; 43(11): 950-954, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34142645
14.
Drug Choices and Advancements for Managing Depression in Parkinson's Disease.
Curr Neuropharmacol
; 18(4): 277-287, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31622207
15.
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside.
Curr Neuropharmacol
; 17(9): 861-873, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30160213